The timed 25-foot walk in a large cohort of multiple sclerosis patients.

Anissa KalinowskiGary CutterNina Bozinov Jessica A Hinman Michael Hittle Robert W Motl Michelle C OddenLorene M Nelson

Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2021)

This research confirms the association of the T25FW with disability and provides some evidence of predictive validity. Our findings support the continued use of the T25FW in clinical practice and clinical trials.

Keyphrases

multiple sclerosis
clinical trial
end stage renal disease
clinical practice
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
white matter
patient reported outcomes
patient reported
phase iii
placebo controlled